|Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial|
SB Kang, JW Park, SY Jeong, BH Nam, HS Choi, DW Kim, SB Lim, ...
The lancet oncology 11 (7), 637-645, 2010
|Predictive and prognostic impact of epidermal growth factor receptor mutation in non–small-cell lung cancer patients treated with gefitinib|
SW Han, TY Kim, PG Hwang, S Jeong, J Kim, IS Choi, DY Oh, JH Kim, ...
Journal of clinical oncology 23 (11), 2493-2501, 2005
|Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority …|
SY Jeong, JW Park, BH Nam, S Kim, SB Kang, SB Lim, HS Choi, DW Kim, ...
The Lancet Oncology 15 (7), 767-774, 2014
|Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy …|
YS Hong, BH Nam, K Kim, JE Kim, SJ Park, YS Park, JO Park, SY Kim, ...
The lancet oncology 15 (11), 1245-1253, 2014
|Optimization of patient selection for gefitinib in non–small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt …|
SW Han, TY Kim, YK Jeon, PG Hwang, SA Im, KH Lee, JH Kim, DW Kim, ...
Clinical Cancer Research 12 (8), 2538-2544, 2006
|Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer|
AN Seo, HJ Lee, EJ Kim, HJ Kim, MH Jang, HE Lee, YJ Kim, JH Kim, ...
British journal of cancer 109 (10), 2705-2713, 2013
|Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance|
H Seol, HJ Lee, Y Choi, HE Lee, YJ Kim, JH Kim, E Kang, SW Kim, ...
Modern pathology 25 (7), 938-948, 2012
|Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis|
B Keam, SA Im, KH Lee, SW Han, DY Oh, JH Kim, SH Lee, W Han, ...
Breast Cancer Research 13 (2), 1-7, 2011
|Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer|
JW Kim, KH Nam, SH Ahn, DJ Park, HH Kim, SH Kim, H Chang, JO Lee, ...
Gastric cancer 19 (1), 42-52, 2016
|High EGFR gene copy number predicts poor outcome in triple-negative breast cancer|
HS Park, MH Jang, EJ Kim, HJ Kim, HJ Lee, YJ Kim, JH Kim, E Kang, ...
Modern pathology 27 (9), 1212-1222, 2014
|Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the …|
B Keam, SA Im, HJ Kim, DY Oh, JH Kim, SH Lee, EK Chie, W Han, ...
BMC cancer 7 (1), 1-11, 2007
|Phase II study of oxaliplatin, 5-fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer|
DY Kim, JH Kim, SH Lee, TY Kim, DS Heo, YJ Bang, NK Kim
Annals of oncology 14 (3), 383-387, 2003
|An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer|
HE Lee, JH Kim, YJ Kim, SY Choi, SW Kim, E Kang, IY Chung, IA Kim, ...
British journal of cancer 104 (11), 1730-1738, 2011
|Promoter CpG island hypermethylation during breast cancer progression|
SY Park, HJ Kwon, HE Lee, HS Ryu, SW Kim, JH Kim, IA Kim, N Jung, ...
Virchows Archiv 458 (1), 73-84, 2011
|Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy|
HW Jung, JW Kim, JY Kim, SW Kim, HK Yang, JW Lee, KW Lee, DW Kim, ...
Supportive care in cancer 23 (3), 687-694, 2015
|The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer|
J Rhee, SW Han, DY Oh, JH Kim, SA Im, W Han, I Ae Park, DY Noh, ...
BMC cancer 8 (1), 1-8, 2008
|Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer|
MJ Kim, HS Lee, JH Kim, YJ Kim, JH Kwon, JO Lee, SM Bang, KU Park, ...
BMC cancer 12 (1), 1-10, 2012
|Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era|
JH Park, YJ Kim, JO Lee, KW Lee, JH Kim, SM Bang, JH Chung, JS Kim, ...
Lung Cancer 76 (3), 387-392, 2012
|The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery|
YH Yun, YA Kim, YH Min, S Park, YJ Won, DY Kim, IJ Choi, YW Kim, ...
Annals of oncology 23 (10), 2731-2737, 2012
|JARID1B Is a Luminal Lineage-Driving Oncogene in Breast Cancer|
S Yamamoto, Z Wu, HG Russnes, S Takagi, G Peluffo, C Vaske, X Zhao, ...
Cancer cell 25 (6), 762-777, 2014